Hexagon Nutrition profit and loss

Latest FY26

Revenue: ₹383cr
EBITDA: ₹52.6cr
Net profit: ₹37.9cr
EPS: ₹3.43

₹ crore except per share

Tap a line for its trend	FY26Mar 2026

Expenses
	383
	11.9
	395
	202
	0.3
	−3.2
	50.4
	4.0
	9.6
	80.1
	344
	52.6
	43.0
Profit
	50.9
	0.3
	51.2
	13.4
	−0.1
	13.2
	37.9
	37.9
	1.2
	39.1
	37.9
Per share
	₹3.43
	₹3.09
Other comprehensive income — detail
	1.2
	1.2
	39.1
Per share — as-filed variants
	₹3.43
	₹3.09
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	183
	47.9%
Adjusted (ex-exceptional items) — derived
	50.9
	0.3
	37.7
	₹3.41

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HEXAGON₹57.32

Hexagon Nutrition Limited

· Pharma & Health

Annual Quarterly₹ CroreMcap ₹634 Cr

View

	In ₹ Crore except Per Share 12 Months Ending	FY26 31/03/2026
	Revenue from Operations	382.6
	Other Income	11.9
	Total Income	394.6
	Expenses
	+ Cost of Materials Consumed	202.5
	+ Purchases of Stock-in-Trade	0.3
	+ Changes in Inventories	-3.2
	+ Employee Benefit Expense	50.4
	+ Finance Costs	4.0
	+ Depreciation & Amortisation	9.6
	+ Other Expenses	80.1
	Total Expenses	343.7
	EBITDA	52.6
	EBIT	43.0
	Profit
	PBT before Exceptional Items	50.9
	+ Exceptional Items	0.3
	Pretax Income	51.2
	+ Current Tax	13.4
	+ Deferred Tax	-0.1
	Tax Expense	13.2
	Net Income	37.9
	+ Net Income — Continuing Ops	37.9
	+ Other Comprehensive Income	1.2
	Total Comprehensive Income	39.1
	Net Income to Common	37.9
	Per Share
	Basic EPS	3.43
	Diluted EPS	3.09
	Other Comprehensive Income — detail
	+ Other Comprehensive Income	1.2
	+ Items NOT to be Reclassified to P&L	1.2
	Comprehensive Income — Owners of Parent	39.1
	Per Share — as-filed variants
	Basic EPS — Continuing Operations	3.43
	Diluted EPS — Continuing Operations	3.09
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	183.1
	Gross Margin %	47.85
	Adjusted (ex-Exceptional Items) — derived
	Pretax Income (Adjusted, as filed)	50.9
	− Exceptional Items (reconciliation)	0.3
	Net Income Adj (tax-effected)	37.7
	EPS Adj	3.41
	Other Filed Concepts — mapped but not yet placed in the schedule
	Face Value	1.00
	Paid Up Equity Capital	11.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.